Anti-OTOGL/ C12orf64/ DFNB84B functional antibody

Anti-OTOGL/ C12orf64/ DFNB84B functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to OTOGL/OTOGL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1162-Ab-1/ GM-Tg-hg-SE1162-Ab-2Anti-Human OTOGL monoclonal antibodyHuman
GM-Tg-rg-SE1162-Ab-1/ GM-Tg-rg-SE1162-Ab-2Anti-Rat OTOGL monoclonal antibodyRat
GM-Tg-mg-SE1162-Ab-1/ GM-Tg-mg-SE1162-Ab-2Anti-Mouse OTOGL monoclonal antibodyMouse
GM-Tg-cynog-SE1162-Ab-1/ GM-Tg-cynog-SE1162-Ab-2Anti-Cynomolgus/ Rhesus macaque OTOGL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1162-Ab-1/ GM-Tg-felg-SE1162-Ab-2Anti-Feline OTOGL monoclonal antibodyFeline
GM-Tg-cang-SE1162-Ab-1/ GM-Tg-cang-SE1162-Ab-2Anti-Canine OTOGL monoclonal antibodyCanine
GM-Tg-bovg-SE1162-Ab-1/ GM-Tg-bovg-SE1162-Ab-2Anti-Bovine OTOGL monoclonal antibodyBovine
GM-Tg-equg-SE1162-Ab-1/ GM-Tg-equg-SE1162-Ab-2Anti-Equine OTOGL monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1162-Ab-1/ GM-Tg-hg-SE1162-Ab-2; GM-Tg-rg-SE1162-Ab-1/ GM-Tg-rg-SE1162-Ab-2;
GM-Tg-mg-SE1162-Ab-1/ GM-Tg-mg-SE1162-Ab-2; GM-Tg-cynog-SE1162-Ab-1/ GM-Tg-cynog-SE1162-Ab-2;
GM-Tg-felg-SE1162-Ab-1/ GM-Tg-felg-SE1162-Ab-2; GM-Tg-cang-SE1162-Ab-1/ GM-Tg-cang-SE1162-Ab-2;
GM-Tg-bovg-SE1162-Ab-1/ GM-Tg-bovg-SE1162-Ab-2; GM-Tg-equg-SE1162-Ab-1/ GM-Tg-equg-SE1162-Ab-2
Products NameAnti-OTOGL monoclonal antibody
Formatmab
Target NameOTOGL
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OTOGL benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1162-Ag-1Recombinant multi-species OTOGL/ C12orf64/ DFNB84B protein


    Target information

    Target IDGM-SE1162
    Target NameOTOGL
    Gene ID283310,628870,685868,696548,611522,101090531,531410,100060599
    Gene Symbol and SynonymsC12orf64,DFNB84B,EG628870,Gm6924,OTOGL,Otogl-ps1,RGD1564294
    Uniprot AccessionQ3ZCN5
    Uniprot Entry NameOTOGL_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000165899
    Target ClassificationN/A

    The target: OTOGL, gene name: OTOGL, also named as C12orf64, DFNB84B. The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.